ClinicalTrials.gov
ClinicalTrials.gov Menu

Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01925820
Recruitment Status : Recruiting
First Posted : August 20, 2013
Last Update Posted : December 4, 2014
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by (Responsible Party):
National Taiwan University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2018
  Study Completion Date : No date given